TriSalus Life Sciences, Inc. (TLSI)

TriSalus Life Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-55.45	-59.04	-47.19	-28.85	-31.83
Depreciation & Amortization	0.75	0.7	0.4	0.46	0.32
Other Amortization	0.43	-	-	1.74	5.97
Loss (Gain) From Sale of Assets	0.19	0.23	0.31	-0	0.04
Stock-Based Compensation	4.74	1.4	0.37	0.11	0.02
Other Operating Activities	11.38	5.92	11.5	3.97	9
Change in Accounts Receivable	-1.86	-1.98	-0.2	-0.74	-0.42
Change in Inventory	-2.37	-1.07	-0.18	-0.73	0.76
Change in Accounts Payable	0.93	2.84	5.25	3.18	-0.03
Change in Other Net Operating Assets	-2.74	0.95	-2.57	-1.84	0.59
Operating Cash Flow	-43.99	-50.05	-32.31	-22.7	-15.58
Capital Expenditures	-0.67	-0.59	-0.66	-1.1	-0.55
Cash Acquisitions	-1	-1	-1	-1	-
Sale (Purchase) of Intangibles	-0.33	-0.53	-0.13	-0.16	-0.16
Other Investing Activities	1	-	-	-	-9
Investing Cash Flow	-1	-2.12	-1.79	-2.26	-9.7
Long-Term Debt Issued	-	-	-	0.05	25.48
Long-Term Debt Repaid	-	-0.09	-0.13	-1.35	-0.7
Net Debt Issued (Repaid)	24.91	-0.09	-0.13	-1.3	24.78
Issuance of Common Stock	12.69	0.18	0.09	0.05	0.01
Other Financing Activities	-2.61	35.72	-	-	-
Financing Cash Flow	34.99	54.63	13.46	50.77	24.81
Net Cash Flow	-10	2.46	-20.64	25.81	-0.48
Free Cash Flow	-44.65	-50.63	-32.97	-23.79	-16.13
Free Cash Flow Margin	-166.04%	-273.53%	-265.91%	-283.23%	-296.74%
Free Cash Flow Per Share	-1.84	-5.39	-106.48	-2.68	-2.10
Cash Interest Paid	-	-	-	0.02	0.05
Cash Income Tax Paid	0.01	0.01	0.01	0	-
Levered Free Cash Flow	-33.34	-51.81	-0.15	-24.49	-
Unlevered Free Cash Flow	-32.51	-51.8	-0.15	-25.13	-
Change in Net Working Capital	4.14	18.94	-22.64	9.43	-

Source: S&P Capital IQ. Standard template. Financial Sources.